Updates are available Correction dated 2025-10-04
Click to view Correction: https://doi.org/10.1038/s42003-025-08894-z
-
Authors
Fan, Jingqi
Gillespie, Kevin P.
Mesaros, Clementina
Blair, Ian A. https://orcid.org/0000-0003-0366-8658
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (P30ES013508, P30ES013508)
U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences
- License Information
-
More Information
Article History
Received: 26 March 2024
Accepted: 20 September 2024
First Online: 1 October 2024
Change Date: 4 October 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s42003-025-08894-z
Competing interests
: I.A.B. has sponsored research agreements with Lexeo Therapeutics and Design Therapeutics. A provisional patent is pending for CT-HMGB2 and its analogs.
